Status:
UNKNOWN
Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment
Lead Sponsor:
Royal National Orthopaedic Hospital NHS Trust
Conditions:
MAGEC Rod
Eligibility:
All Genders
Brief Summary
Magnetic Expansion Control (MAGEC) growth rods are used in the surgical treatment of children with scoliosis; the primary constituent metal alloy in these is titanium. Since June 2019, the manufactur...
Eligibility Criteria
Inclusion
- Patients that have been treated with, and still have, a MAGEC rod.
Exclusion
- Patients that do not have a MAGEC rod implant.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04337151
Start Date
April 1 2020
End Date
March 1 2021
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal National Orthopaedic Hospital
Stanmore, United Kingdom, HA74LP